A Single Tertiary Center 14-year Experience With Mesenteric Panniculitis in Turkey: A Retrospective Study of 716

Hüseyin Atacan1, Murat Erkut2, Ferhat Değirmenci3

  • 1Department of Internal Medicine, Bulancak State Hospital, Giresun, Turkey.

Abstract

Insights

Mesenteric panniculitis affects 1.1% of patients. Malignancy is common, particularly in older patients with specific clinical, laboratory, and radiological findings, warranting further investigation.

Area of Science:

  • Gastroenterology
  • Radiology
  • Oncology

Background:

  • Mesenteric panniculitis is a rare chronic inflammatory condition affecting the mesentery.
  • It is characterized by lipodystrophy and fibrosis of the mesenteric adipose tissue.
  • Computed tomography (CT) is crucial for diagnosis and assessing associated conditions.

Purpose of the Study:

  • To determine the prevalence of mesenteric panniculitis.
  • To analyze the clinical, laboratory, and radiological features of patients diagnosed with mesenteric panniculitis.
  • To investigate the association between mesenteric panniculitis and malignancy.

Main Methods:

  • Retrospective analysis of 716 patients diagnosed with mesenteric panniculitis via CT scans.
  • Data collected between January 2005 and December 2018 from a cohort of 65,278 patients.
  • Comparison of demographic, clinical, laboratory, and radiological data between malignant and non-malignant groups.

Main Results:

  • Mesenteric panniculitis prevalence was 1.1% (716/65,278 patients).
  • Nearly half (49.4%) of patients had associated malignancy, with a higher mean age in this group.
  • Key differentiating factors included history of abdominal surgery, lower hemoglobin/leukocyte counts, higher ESR, and specific CT findings.

Conclusions:

  • Malignancy is a significant comorbidity in patients with mesenteric panniculitis.
  • High-risk clinical, laboratory, and radiological features necessitate further oncological investigation.
  • Early detection and management strategies are crucial for improving patient outcomes.